News & Events

News &

Tarsier Pharma's CEO and Founder, Dr. Daphne Haim-Langford Interviewed on NYSE Floor Talk

June 4, 2024

Tarsier Pharma is pleased to announce that its CEO and Founder, Dr. Daphne Haim-Langford, was recently interviewed on the esteemed program NYSE Floor Talk, hosted by Judy Shaw. In this engaging and insightful interview, Dr. Haim-Langford delves into Tarsier’s groundbreaking innovation and shared why advancing Dazdatuftide (TRS) has become her life mission. Watch this interesting and inspiring interview below.



About NYSE Floor Talk

NYSE Floor Talk with Judy Shaw is a premier interview series for business leaders, innovators, and newsmakers.

About Tarsier Pharma

Tarsier Pharma is a clinical stage biopharmaceutical company, focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat immune-mediated blinding diseases in the front and back of the eye.


Investor Relations Tarsier Pharma

[email protected]

Scroll to Top